Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice

Nature Medicine

Volumn 3, Issue 11, 1997, Pages 1216-1221

  Deconinck, Nicolas ^a   Tinsley, Jonathon ^b   De Backer, Fabienne ^a   Fisher, Rosie ^b   Kahn, David ^a   Phelps, Steve ^b   Davies, Kay ^b   Gillis, Jean Marie ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; UTROPHIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; DUCHENNE MUSCULAR DYSTROPHY; MUSCLE ATROPHY; MUSCLE FORCE; MUSCLE FUNCTION; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSGENE;

EID: 0030723508     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197-1216     Document Type: Article

References (35)

1. Blake, D.J., Tinsley, J.M. & Davies, K.E. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol. 6, 37-47 (1996).
2. Tinsley, J.M. et al. Primary structure of dystrophin-related protein. Nature 360, 591-592 (1992).
3. Pons, F. et al. A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice: Immunological evidence. FEBS Lett. 282, 161-165 (1991).
4. Matsumura, K., Ervasti, J., Ohlendieck, K., Kahl, S. & Campbell, K. Association of dystrophin-related protein with dystrophin associated proteins in mdx mouse muscle. Nature 360, 588-591 (1993).
5. Mizumo, Y., Nonaka, I., Hirai, S. & Ozawa, E. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD carriers and control subjects. J. Neurol. Sci. 119, 43-52 (1993).
6. Karpati, G. et al. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52, 119-128 (1993).
7. Tinsley, J.M. & Davies, K.E. Utrophin: A potential replacement for dystrophin? Neuromusc. Disord. 3, 537-539 (1993).
8. Ragot, Th. et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647-650 (1993).
9. Phelps, S.F. et al. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet, 4, 1251-1258 (1995).
10. Deconinck, N., Ragot, T., Maréchal, G., Pérricaudet, M. & Gillis, J.M. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93, 3570-3574 (1996).
11. Tinsley, J.M. et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349-353 (1996).
12. Karpati, G. Utrophin muscles in on the action. Nature Med. 3, 22-23 (1997).
13. Coulton, G.R., Curtin, N.A., Morgan, J.E. & Partridge, T.A. The mdx mouse skeletal muscle myopathy. II. Contractile properties. Neuropathol. Appl. Neurobiol. 14, 299-314 (1988).
14. Stedman, H.H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536-539 (1991).
15. Weller, B., Karpati, G. & Carpenter, S. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100, 9-13 (1990).
16. Moens, P., Baatsen, P.H.W.W. & Maréchal, G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J. Musc. Res. Cell Motil. 14, 446-451 (1993).
17. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. & Sweeney, H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714 (1993).
18. Carlson, C.G. & Makiejus, R.V. A non-invasive procedure to detect muscle weakness in the mdx mouse. Muscle Nerve 13, 480-484 (1990).
19. Bodensteiner, J.B. & Engel, A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567,000 muscle fibres in 114 biopsies. Neurology 28, 439-446 (1978).
20. Gailly, Ph., Boland, B., Himpens, B., Casteels, R. & Gillis, J.M. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium 14, 473-483 (1993).
21. Head, S.I. Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. J. Physiol. 469, 11-19 (1993).
22. 2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres Pfluegers Arch. 426, 499-505 (1994).
23. Turner, P.R., Fong, P., Denetclaw, W.F. & Steinhardt, R.A. Increased calcium influx in dystrophic muscle J. Cell Biol. 115, 1701-1712 (1991).
24. Leijendekker, W.J., Passaquin, A.C., Metzinger, L. & Rüegg, U.T. Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress Br. J. Pharmacol. 118, 611-616 (1996).
25. 2+ indicators with greatly improved fluorescent properties. J. Biol. Chem. 260, 3440-50 (1985).
26. Sunada, Y. & Campbell, K. Dystrophin-glycoprotein complex: Molecular organization and critical roles in skeletal muscle Curr. Opin. Neurol. 8, 379-384 (1995).
27. Takeshima, Y. et al. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype. Neurology 44, 1648-1651 (1994).
28. 2 terminal F-actin binding domain of utrophin. FEBS Lett. 357, 125-128 (1995).
29. Sugita, H., Takemitsu, M., Koga, R., Ishiura, S. & Arahata, K. The expression of utrophin in mdx mouse muscle dystrophy. Acta Cardiomiol. 5, 11-16 (1993).
30. Haws, C.M. & Lansman, J.B. Developmental regulation of mechanosensitive calcium channels in skeletal muscle from normal and mdx mice. Proc. R. Soc. Lond. B 245, 173-177 (1991).
31. McArdle, A., Edwards, R.H.T. & Jackson, M.J. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17, 1378-1384 (1994).
32. Menke, A. & Jockusch, H. Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349, 69-71 (1991).
33. Webster, C., Silberstein, L., Hays, A.P. & Blau, H.M. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52, 502-13 (1988).
34. Bailey, N.T. Statistical Methods in Biology (English Univ. Press, London, 1959).
35. Cox, G.A. et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364, 725-729 (1993).